Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited)

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Revenues:        
License and collaborative fees $ 1,201 $ 605 $ 2,164 $ 1,003
Contract and other 4,772 6,546 7,219 15,602
Total revenues 5,973 7,151 9,383 16,605
Operating expenses:        
Research and development 19,590 17,070 41,136 33,707
Selling, general and administrative 5,160 4,081 10,414 8,203
Restructuring 0 79 84 97
Total operating expenses 24,750 21,230 51,634 42,007
Loss from operations (18,777) (14,079) (42,251) (25,402)
Other (expense) income, net:        
Interest expense (1,110) (1,164) (2,236) (2,336)
Other income (expense), net 27 (224) (61) 224
Revaluation of contingent warrant liabilities 7,963 (1,781) 27,964 (14,621)
Net loss (11,897) (17,248) (16,584) (42,135)
Basic net loss per share of common stock (in shares) $ (0.11) $ (0.21) $ (0.16) $ (0.51)
Diluted net loss per share of common stock (in shares) $ (0.17) $ (0.21) $ (0.38) $ (0.51)
Shares used in computing basic net loss per share of common stock (in shares) 106,927 82,939 106,545 82,768
Shares used in computing diluted net loss per share of common stock 114,126 82,939 115,048 82,768
Other comprehensive loss:        
Net loss (11,897) (17,248) (16,584) (42,135)
Net unrealized (loss) gain on available-for-sale securities (1) (11) 7 (8)
Comprehensive loss $ (11,898) $ (17,259) $ (16,577) $ (42,143)